Treace_color.jpg
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
January 08, 2024 07:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023 07:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
November 09, 2023 16:05 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace to Present at Stifel 2023 Healthcare Conference
October 30, 2023 07:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace to Report Third Quarter 2023 Financial Results
October 16, 2023 07:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace_color.jpg
Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
September 20, 2023 07:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
September 14, 2023 16:05 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
September 11, 2023 16:05 ET | Treace Medical Concepts, Inc.
Further Expands Market Opportunity to Include Hammertoe Correction Company Receives 510(k) Clearance for Second-Generation SpeedPlate™ Implant Fixation Platform Ahead of Full Market Launch in Fourth...
Treace_color.jpg
Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference
August 22, 2023 16:05 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing
August 21, 2023 07:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...